European Union - English - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies).to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies.to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies).mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - mycoplasma hyopneumoniae - inactivated antigen; thiomersal - misc. vaccines or anti sera - mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 31600.0 ru/2ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - mycoplasma hyopneumoniae | pneumonia | bacterial pneumonia | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - mycoplasma pneumoniae (unii: jqe470fad0) (mycoplasma pneumoniae - unii:jqe470fad0) - mycoplasma pneumoniae 15 [hp_x] in 1 ml - for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, and nausea.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, and nausea.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - mycoplasma pneumoniae (unii: jqe470fad0) (mycoplasma pneumoniae - unii:jqe470fad0) - mycoplasma pneumoniae 15 [hp_x] in 1 ml - for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, nausea, lymph node pain, cognitive problems, depression, and breathing problems.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, nausea, lymph node pain, cognitive problems, depression, and breathing problems.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - mycoplasma hyopneumoniae strain j; thiomersal - misc. vaccines or anti sera - mycoplasma hyopneumoniae strain j vaccine-general active 1.0 rp; thiomersal mercury other 0.01 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - mycoplasma hyopneumoniae | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - mycoplasma gallisepticum strain ts-11 - misc. vaccines or anti sera - mycoplasma gallisepticum strain ts-11 vaccine-general active 0.0 ccu/dose - immunotherapy - poultry layers (eggs for human consump) | caged layers | chickens | chooks | hen - chronic respiratory disease | mycoplasma gallisepticum | vaccine | chronic respiratory disease (c | equine rotavirus | infectious sinusitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - mycoplasma hyopneumoniae - inactivated antigen - unknown - mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 0.0 - active constituent

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

elanco - mycoplasma hyopneumoniae (inactivated) min. 6000 ur/dose - emulsion for injection - mycoplasma hyopneumoniae, inactivated - mycoplasma - pig

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - mycoplasma synoviae strain ms-h vaccine, living - misc. aural, ophthalmic, oro/naso pharyngeal - mycoplasma synoviae strain ms-h vaccine, living vaccine-general active 105.7 ccu/dose - immunotherapy - poultry broilers (meat for human consum) | poultry layers (eggs for human consump) | poultry pullets (growing chook) | breeding - airsacculitis | chronic respiratory disease | infectious synovitis | vaccine | equine rotavirus | ms

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - mycoplasma hyopneumonide bacterin; thiomersal - misc. vaccines or anti sera - mycoplasma hyopneumonide bacterin vaccine-general active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - mycoplasma hyopneumoniae | reduction of lung lesions | respiratory disease | swine enzootic pneumonia